Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Disseminated Intravascular Coagulation (DIC) Market from 2024 to 2025?
The market size for disseminated intravascular coagulation (DIC) has demonstrated substantial growth in recent times. The market is expected to expand from $0.46 billion in 2024 to $0.49 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.3%. The increase during the historical period is due to factors such as a surge in sepsis instances, an increase in trauma incidents, a rise in cancer incidence, elevated healthcare expenditure, improved cognizance among healthcare practitioners, and an upsurge in the adoption of targeted therapies.
What Is the Projected Market Size of the Disseminated Intravascular Coagulation (DIC) Market?
The future is promising for the disseminated intravascular coagulation (DIC) market, as it is projected to experience substantial expansion in the coming years. By 2029, the DIC market is estimated to reach a value of $0.59 billion, growing at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth is driven by factors such as increased utilization of targeted therapies, an emphasis on early detection of diseases, burgeoning investments in healthcare infrastructure, the widening scope of clinical research for coagulopathy treatments, and a growing awareness of rare hematology-related diseases. The forecast period will observe trends like advancements in diagnostic tests, the implementation of cutting-edge anticoagulant therapies, customized medicine strategies, application of artificial intelligence in diagnostic processes, optimized patient supervision technology, and creation of specific treatments.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
Who are the Major Competitors in the Disseminated Intravascular Coagulation (DIC) Market Outlook?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.
What Is Fueling Growth in the Disseminated Intravascular Coagulation (DIC) Market?
The surge in cancer cases is anticipated to fuel the expansion of the disseminated intravascular coagulation (DIC) market in the future. Cancer, marked by rampant growth and proliferation of rogue cells that can infiltrate and destroy healthy tissue in the body, is on an upward trend due to elements such as an aging population, lifestyle modifications, exposure to the environment, infections, and genetic predisposition. Disseminated intravascular coagulation (DIC) can be triggered by cancer as it induces excessive activation of the coagulation cascade via tumor-formed procoagulant substances, propelling widespread clotting and bleeding. For instance, data from the National Cancer Institute, a governmental agency based in the US, from May 2024 indicates that there were roughly 20 million new instances of cancer and 9.7 million cancer-associated fatalities globally in 2022. These figures are estimated to rise to 29.9 million fresh cases and 15.3 million deaths yearly by 2040. Thus, the escalating prevalence of cancer is stimulating the expansion of the disseminated intravascular coagulation (DIC) market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21172&type=smp
Which Disseminated Intravascular Coagulation (DIC) Market Segments Are Growing the Fastest?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented –
1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy
Which Industry Trends Are Shaping the Future of the Disseminated Intravascular Coagulation (DIC) Market?
Companies at the forefront of the disseminated intravascular coagulation (DIC) market are concentrating their efforts on evolving coagulation diagnostic technologies. These advancements, such as next-generation clotting tests, aim to increase diagnostic speed, accuracy, and convenience, thereby ensuring faster treatment and better patient prognosis. Next-generation clotting tests include sophisticated diagnostic tools and techniques that provide a more detailed, efficient and accurate evaluation of blood coagulation compared to conventional tests. As an illustration, in June 2022, UK-based healthcare firm LumiraDx Limited broadened its cardiovascular testing range, obtaining CE Mark approvals for its updated D-Dimer and NT-proBNP tests. These introductions have further enhanced LumiraDx Platform’s potential in aiding clinicians diagnose heart failure and exclude venous thromboembolism at the point of care. All of these advances are targeted at enhancing early detection and treatment of cardiovascular and thrombotic diseases, including disseminated intravascular coagulation (DIC).
Access The Full Report Here:
Which Countries Are Leading the Disseminated Intravascular Coagulation (DIC) Market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21172
This Report Delivers Insight On:
1. How big is the disseminated intravascular coagulation (dic) market, and how is it changing globally?
2. Who are the major companies in the disseminated intravascular coagulation (dic) market, and how are they performing?
3. What are the key opportunities and risks in the disseminated intravascular coagulation (dic) market right now?
4. Which products or customer segments are growing the most in the disseminated intravascular coagulation (dic) market?
5. What factors are helping or slowing down the growth of the disseminated intravascular coagulation (dic) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model